Skip to main content
Log in

Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Clinical and histological data of children presenting with steroid-resistant nephrotic syndrome and renal biopsy showing focal and segmental glomerulosclerosis from 1980 with a follow-up of over 10 years were reviewed. There were 66 patients; 38 male and 28 female. Age at onset ranged from 0.4–14.1 years (mean 6.4). Tubular atrophy was present at first biopsy in 50/66, capsular adhesions in 35/66, glomerular tip lesions in 8/66 and mesangial expansion in 31/66 patients. In 51 children, cyclophosphamide was prescribed as the first cytotoxic agent, while 15 received cyclosporine A and complete remission was induced in 43 and 40% of the children, respectively. Complete and stable remission was maintained in 35 children, while 22 had reduction of proteinuria with symptomatic relief. Nine were refractory to cytotoxic therapy. Of the 35 patients who entered complete and stable remission, the renal survival was over 90%, while in the 31 non-responders it was 48% in 10 years. The multivariate analysis using unconditional logistic regression method identified the presence of mesangial expansion (p=0.011) and tip lesions (p=0.005) as the independent predictors of favourable response to cytotoxic therapy and the presence of renal impairment (p=0.008) and extensive focal segmental sclerosis (p=0.025) as independent predictors of unfavourable response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. White RHR, Glasgow EF, Mills RJ (1970) Clinicopathological study of nephrotic syndrome in childhood. Lancet 1:1353–1359

    CAS  PubMed  Google Scholar 

  2. Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: natural history and treatment. Nephron 21:75–85

    Article  CAS  PubMed  Google Scholar 

  3. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213–218

    CAS  PubMed  Google Scholar 

  4. Trompeter RS (1989) Immunosuppressive therapy in nephrotic syndrome in children. Pediatr Nephrol 3:218–220

    Article  Google Scholar 

  5. Burgess E (1999) Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int Suppl 55(S70):S26–S32

    Article  Google Scholar 

  6. Habashy D, Hodson EM, Craig JC (2003) Interventions for steroid-resistant nephrotic syndrome: a systematic review. Pediatr Nephrol 18:906–912

    Article  PubMed  Google Scholar 

  7. Abeyagunawardena A, Brogan PA, Trompeter RS, Dillon MJ (2002) Immunosuppressive therapy of childhood idiopathic nephrotic syndrome. Expert Opin Pharmacother 3:513–519

    Article  CAS  PubMed  Google Scholar 

  8. Bazzi C, Petrini C, Rizza V, Arrigo G, D’Amico G (2000) A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 58:1732–1741

    Article  CAS  PubMed  Google Scholar 

  9. Detwiler RK, Falk RJ, Hogan SL, Jennette JC (1994) Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416–1426

    Article  CAS  PubMed  Google Scholar 

  10. Southwest Pediatric Nephrology Study Group (1985) Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27:442–449

    Article  Google Scholar 

  11. Consensus statement on management and audit potential for steroid responsive nephrotic syndrome (1994) Report of a workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians. Arch Dis Child 70:151–157

    Article  Google Scholar 

  12. Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P (1987) Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 82:938–944

    Article  CAS  PubMed  Google Scholar 

  13. Tarshish P, Tobin JN, Bernstein J, Edelmann CM (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10:590–593

    Article  CAS  PubMed  Google Scholar 

  14. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisolone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43:84–88

    CAS  PubMed  Google Scholar 

  15. Martinelli R, Okumura AS, Pereira LJ, Rocha H (2001) Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol 16:658–661

    Article  CAS  PubMed  Google Scholar 

  16. Singh A, Tejani C, Tejani A (1999) One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol 13:26–32

    Article  CAS  PubMed  Google Scholar 

  17. Niaudet P (1994) Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisolone. J Pediatr 125:981–986

    Article  CAS  PubMed  Google Scholar 

  18. Goonasekera CDA, Koziell AB, Hulton SA, Dillon MJ (1998) Vincristine and focal segmental sclerosis: do we need a multicentre trial? Pediatr Nephrol 12:284–289

    Article  CAS  PubMed  Google Scholar 

  19. Abeyagunawardena AS, Abeysekera CK, Thalgahagoda RS, Dillon MJ (2004) Pulsed vincristine therapy in steroid-resistant nephrotic syndrome (abstract). Pediatr Nephrol 6:C119

    Google Scholar 

  20. Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393–397

    Article  CAS  PubMed  Google Scholar 

  21. Kestila M, Lenkkeri U, Lamerdin J (1998) Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582

    Article  CAS  PubMed  Google Scholar 

  22. Niaudet P (2004) Genetic forms of nephrotic syndrome. Pediatr Nephrol 19:1313–1318

    Article  PubMed  Google Scholar 

  23. Yu Z, Ding J, Huang J, Yao Y, Xiao H, Zhang J, Liu J, Yang J (2005) Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children. Nephrol Dial Transplant 20:902–908

    Article  CAS  PubMed  Google Scholar 

  24. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard treatment of nephrotic syndrome. J Am Soc Nephrol 15:722–732

    Article  PubMed  Google Scholar 

  25. Antignac C (2005) Molecular basis of steroid-resistant nephrotic syndrome. Nefrologia 25:25–28

    PubMed  Google Scholar 

  26. Schoeneman MJ, Bennett B, Greifer I (1978) The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children. Clin Nephrol 9:45–54

    CAS  PubMed  Google Scholar 

  27. Stokes MB, Markowitz GS, Lin J, Valeri AM, D’Agati VD (2004) Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 65:1690–1702

    Article  PubMed  Google Scholar 

  28. Ponticelli C (1995) Focal segmental glomerulosclerosis. To treat or not to treat. Nephrol Dial Transplant 10:2351–2354

    Article  CAS  PubMed  Google Scholar 

  29. Shiiki H, Dohi K (2000) Primary focal segmental glomerulosclerosis: clinical course, predictors of renal outcome and treatment. Intern Med 39:606–611

    Article  CAS  PubMed  Google Scholar 

  30. Abrantes MM, Cardoso LS, Lima EM, Penido Silva JM, Diniz JS, Bambirra EA, Oliveira EA (2006) Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis. Pediatr Nephrol 21:1003–1012

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard S. Trompeter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abeyagunawardena, A.S., Sebire, N.J., Risdon, R.A. et al. Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol 22, 215–221 (2007). https://doi.org/10.1007/s00467-006-0264-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-006-0264-6

Keywords

Navigation